Please enter a valid ZIP code

Stopping bleeds Bleed
In hemophilia, a collection of blood in an area, such as a muscle or joint.
quickly is important. The faster you treat a bleed, the sooner you can start to recover.

NovoSeven® RT (Coagulation Factor VIIa [Recombinant]) can be quickly mixed and infused to begin to treat bleeds fast*

  • 94% less infusion Infusion
    The injection of medicine directly into a vein using a needle and syringe.
    volume than plasma Plasma
    The fluid part of the blood that contains clotting factors and other proteins.
    -derived bypassing agents Bypassing agent
    A product that treats a bleed without the need for Factor VIII (8) or Factor IX (9).
  • Takes 2 to 5 minutes to administer Administer
    In hemophilia, to apply to the body through infusion.
  • Can be stored at room temperature (up to 77°F)
  • Comes in 4 vial sizes: 1 mg, 2 mg, 5 mg, and 8 mg

*In patients with hemophilia A or B with inhibitors.
Individual doses compared.


Each vial comes with an appropriately prefilled syringe with diluent.
Indications and Usage

NovoSeven® RT (Coagulation Factor VIIa [Recombinant]) is used for:

Important Safety Information


  • Serious blood clots that form in veins and arteries with the use of NovoSeven® RT have been reported.
  • Your healthcare provider should discuss the risks and explain the signs and symptoms of blood clots to you. Some signs of a blood clot may include pain, swelling, warmth, redness, or a lump in your legs or arms, chest pain, shortness of breath, or sudden severe headache and/or loss of consciousness or function.
  • Your healthcare provider should monitor you for blood clots during treatment with NovoSeven® RT.

Warnings and Precautions

Side Effects

Use with Other Drugs

Please click here for NovoSeven® RT Prescribing Information and Instructions for Use.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit,
or call 1-800-FDA-1088.

NovoSeven® RT is a prescription medicine. Novo Nordisk provides patient assistance for those who qualify. Please call 1-877-NOVO-777 (1-877-668-6777) to learn more about Novo Nordisk assistance programs.